↓ Skip to main content

Neoadjuvant Chemoradiotherapy and Tumor Recurrence in Patients with Early T-Stage Cancer of the Lower Rectum

Overview of attention for article published in Annals of Surgical Oncology, November 2019
Altmetric Badge

Mentioned by

twitter
1 tweeter
Title
Neoadjuvant Chemoradiotherapy and Tumor Recurrence in Patients with Early T-Stage Cancer of the Lower Rectum
Published in
Annals of Surgical Oncology, November 2019
DOI 10.1245/s10434-019-08105-0
Pubmed ID
Authors

Ian P. Hayes, Elasma Milanzi, Peter Gibbs, Jeanette C. Reece

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 December 2019.
All research outputs
#11,189,630
of 14,110,335 outputs
Outputs from Annals of Surgical Oncology
#2,698
of 3,438 outputs
Outputs of similar age
#192,434
of 269,229 outputs
Outputs of similar age from Annals of Surgical Oncology
#97
of 118 outputs
Altmetric has tracked 14,110,335 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,438 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 269,229 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 118 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.